spacer
home > epc > autumn 2008 > home work
PUBLICATIONS
European Pharmaceutical Contractor

Home Work

In recent decades the types of therapy in research and the marketplace have undergone some radical transformations. Where most therapies were once squarely aimed at endemic diseases of the West, the recent biotechnology revolution has hugely increased the number of therapeutic targets, with more complex medicines – often parenteral – aimed at less common illnesses or at more specific sub groups of patients with more common conditions. For example, we are seeing oncology therapies targeting smaller sub groups of patients, the rise of therapies for orphan indications, the targeting of antibodies and proteins for specific complications of illness such as preventing SLE crisis and so on. The drive towards community medicine means an infrastructure has grown up to administer these medicines in the home and to run clinical trials in the same way.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Graham Wylie is CEO of the Medical Research Network Ltd, an affiliate company of Healthcare at Home. Graham, who trained as a physician, has 18 years of experience in clinical trials, starting with 10 years at Pfizer in clinical development and corporate HQ, with roles ranging from project management of trials to global implementation of standard trial processes and IT tools. He then joined Parexel International in 1999 as Medical Director for Northern Europe, progressing to Vice President of Account Management for Europe by 2003. In 2005 he joined Healthcare at Home to develop their clinical trials activities into a full business unit, known as ‘The Medical Research Network’, spinning the division off as a separate company in 2006.
spacer
Dr Graham Wylie
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

Preparation of Pharmaceutical Samples for Metals Analysis

RSSL

There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement